Association of heart rate variability with arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

Circulation Journal

Volumn 76, Issue 3, 2012, Pages 618-623

  Battipaglia, Irma ^a   Scalone, Giancarla ^a   Macchione, Andrea ^a   Pinnacchio, Gaetano ^a   Laurito, Marianna ^a   Milo, Maria ^a   Pelargonio, Gemma ^a   Bencardino, Gianluigi ^a   Bellocci, Fulvio ^a   Pieroni, Maurizio ^a   Lanza, Gaetano A ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy dysplasia; Heart rate variability; Sudden cardiac death; Sustained ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; JT INTERVAL; MALE; PREDICTOR VARIABLE; PROGNOSIS; QRS COMPLEX; QT INTERVAL; SUDDEN DEATH; SYNCOPE;

ADULT; ARRHYTHMIAS, CARDIAC; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DISEASE SUSCEPTIBILITY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84857591087     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1052     Document Type: Article

References (49)

1. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994; 71: 215-218.
2. Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja G, et al. Familial occurrence of right ventricular dysplasia: A study involving nine families. J Am Coll Cardiol 1988; 12: 1222-1228.
3. Cho Y, Park T, Yang DH, Park HS, Chae J, Chae SC, et al. Arrhythmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans. Circ J 2003; 67: 925-928.
4. Nagaoka I, Matsui K, Ueyama T, Kanemoto M, Wu J, Shimizu A, et al. Novel mutation of plakophilin-2 associated with arrhythmogenic right ventricular cardiomyopathy. Circ J 2006; 70: 933-935.
5. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541.
6. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-133.
7. Furlanello F, Bertoldi A, Dallago M, Furlanello C, Fernando F, Inama G, et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 1998; 21: 331-335.
8. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006; 296: 1593-1601.
9. Hamilton RM, Fidler L. Right ventricular cardiomyopathy in the young: An emerging challenge. Heart Rhythm 2009; 6: 571-575.
10. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 1997; 30: 1512-1520.
11. Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long term follow-up in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J 1989; 10(Suppl D): 68-73.
12. Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994; 127: 1151-1158.
13. Tavernier R, Gevaert S, de Sutter J, De Clercq A, Rottiers H, Fonteyne W. Long term results of cardioverter defibrillator in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001; 85: 53-56.
14. Rougin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004; 43: 1843-1852.
15. Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Long-term experience of a tertiary care center. Heart 2005; 91: 1167-1172.
16. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; 122: 1144-1152.
17. Osaka M, Watanabe E, Murata H, Fuwamoto Y, Nanba S, Sakai K, et al. V-shaped trough in autonomic activity is a possible precursor of life-threatening cardiac events. Circ J 2010; 74: 1906-1915.
18. Okuyama Y. Tactics for the reduction of inappropriate implantable cardioverter defibrillator shocks. Circ J 2010; 74: 1290-1291.
19. Moss AJ. What we have learned from the family of multicenter automatic defibrillator implantation trials. Circ J 2010; 74: 1038-1041.
20. Battipaglia I, Barone L, Mariani L, Infusino F, Remoli R, Careri G, et al. Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 2010; 12: 1725-1731.
21. Lanza GA, Guido V, Galeazzi MM, Mustilli M, Natali R, Ieradi C, et al. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol 1998; 82: 1323-1328.
22. Galinier M, Pathak A, Fourcade J, Androdias C, Curnier D, Varnous S, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 2000; 21: 475-482.
23. Hartikainen JE, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996; 28: 296-304.
24. Ikeda T, Yusu S, Nakamura K, Yoshino H. Risk stratification for sudden cardiac death. Circ J 2007; 71(Suppl A): A106-A114.
25. Santangeli P, Infusino F, Sgueglia GA, Sestito A, Lanza GA. Ventricular late potentials: A critical overview and current applications. J Electrocardiol 2008; 41: 318-324.
26. Lander P, Berbari EJ, Rajagopalan CV, Vatterott P, Lazzara R. Critical analysis of the signal-averaged electrocardiogram: Improved identification of late potentials. Circulation 1993; 87: 105-117.
27. Lanza GA. The electrocardiogram as a prognostic tool for predicting major cardiac events. Prog Cardiovas Dis 2007; 50: 87-111.
28. Pieroni M, Dello Russo A, Marzo F, Pelargonio G, Casella M, Bellocci F, et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2009; 53: 681-689.
29. Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Risk stratification and therapy. Prog Cardiovasc Dis 2008; 50: 282-293.
30. Folino AF, Bauce B, Frigo G, Nava A. Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: Correlation with arrhythmic events and echocardiographic findings. Europace 2006; 8: 423-429.
31. Turrini P, Angelini A, Thiene G, Buja G, Daliento L, Rizzoli G, et al. Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 1999; 15: 1214-1219.
32. Nava A, Folino AF, Bauce B, Turrini P, Buja GF, Daliento L, et al. Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias. Eur Heart J 2000; 21: 58-65.
33. Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007; 18: 123-127.
34. Folino AF, Buja G, Bauce B, Thiene G, Dalla Volta S, Nava A. Heart rate variability in arrhythmogenic right ventricular cardiomyopathy correlation with clinical and prognostic features. Pacing Clin Electrophysiol 2002; 25: 1285-1292.
35. Volders PG. Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis. Heart Rhythm 2010; 7: 1900-1906.
36. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
37. Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Eur Heart J 1996; 17: 354-381.
38. Corrado D, Basso C, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: Current diagnostic and management strategies. Cardiol Rev 2001; 9: 259-265.
39. Malik M, Farrell T, Cripps T, Camm AJ. Heart rate variability relation to prognosis after myocardial infarction: Selection of optimal processing techniques. Eur Heart J 1989; 10: 1060-1074.
40. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003; 107: 565-570.
41. Guzzetti S, La Rovere MT, Pinna GD, Maestri R, Borroni E, Porta A, et al. Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure. Eur Heart J 2005; 26: 357-362.
42. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250-258.
43. Schulze RA Jr, Humphries JO, Griffith LS, Ducci H, Achuff S, Baird MG, et al. Left ventricular and coronary angiographic anatomy: Relationship to ventricular irritability in the late hospital phase of acute myocardial infarction. Circulation 1977; 55: 839-843.
44. Casolo GC, Stroder, Sulla A, Chelucci A, Freni A, Zerauschek M. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease. Eur Heart J 1995; 16: 360-367.
45. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 1992; 67: 482-485.
46. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Determinants of heart rate variability. J Am Coll Cardiol 1996; 28: 1539-1546.
47. Chess GF, Tam RMK, Calaresu FR. Influences of cardiac neural imputs on rhythmic variations of heart rate period in the cat. Am J Physiol 1975; 228: 775-780.
48. Goldsmith RL, Bigger JT Jr, Steinman RC, Fleiss JL. Comparison of 24-hour parasympathetic activity in endurance-trained and untrained young men. J Am Coll Cardiol 1992; 20: 552-558.
49. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death: New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78: 969-979.